Key result
The proteasome pathway was specifically enriched in serrated colorectal carcinoma, and TRAF6 and ATN1 were identified as central hub genes that may serve as biomarkers to distinguish it from conventional colorectal carcinoma.
p-value: p=7.18E-08
The proteasome pathway and hub genes TRAF6 and ATN1 may serve as potential biomarkers to distinguish serrated from conventional colorectal carcinoma.
May distinguish SCRC from CCRC molecularly; leaves open clinical translation pending validation.
The aim of this study was to identify the molecular events that distinguish serrated colorectal carcinoma (SCRC) from conventional colorectal carcinoma (CCRC) through differential gene expression, pathway and protein-protein interaction (PPI) network analysis. The GSE4045 and GSE8671 microarray datasets were downloaded from the Gene Expression Omnibus database. We identified the genes that are differentially expressed between SCRC and normal colon tissues, CCRC and healthy tissues, and between SCRC and CCRC using Student's t-tests and Benjamini‑Hochberg (BH) multiple testing corrections. The differentially expressed genes (DEGs) were then mapped to Kyoto Encyclopedia of Genes and Genomes (KEGG) pathways and their enrichment for specific pathways was investigated using the Database for Annotation, Visualization and Integrated Discovery (DAVID) tool with a significance threshold of 0.1. Analysis of the potential interactions between the protein products of 220 DEGs (between CCRC and SCRC) was performed by constructing a PPI network using data from the high performance RDF database (P<0.1). The interaction between pathways was also analyzed in CCRC based on the PPI network. Our study identified thousands of genes differentially expressed in SCRC and CCRC compared to healthy tissues. The DEGs in SCRC and CCRC were enriched in cell cycle, DNA replication, and base excision repair pathways. The proteasome pathway was significantly enriched in SCRC but not in CCRC after BH adjustment. The PPI network showed that tumour necrosis factor receptor-associated factor 6 (TRAF6) and atrophin 1 (ATN1) were the most central genes in the network, with respective degrees of node predicted at 90 and 88. In conclusion, the preoteasome pathway was shown to be specifically enriched in SCRC. Furthermore, TRAF6 and ATN1 may be promising biomarkers for the distinction between serrated and conventional CRC.
No takes yet. Share an insight, caveat, or question.
Chen et al. (2014) studied Colorectal carcinoma (serrated and conventional) (n=101). Serrated colorectal carcinoma vs. Conventional colorectal carcinoma and healthy mucosa was evaluated on Differentially expressed genes and enriched molecular pathways (p=7.18E-08). The proteasome pathway was specifically enriched in serrated colorectal carcinoma, and TRAF6 and ATN1 were identified as central hub genes that may serve as biomarkers to distinguish it from conventional colorectal carcinoma.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: